 | • レポートコード：MRC2312MG08521 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学＆材料 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のポリペプチドAPI市場規模と予測を収録しています。・世界のポリペプチドAPI市場：売上、2018年-2023年、2024年-2029年 ・世界のポリペプチドAPI市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のポリペプチドAPI市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「インスリン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ポリペプチドAPIのグローバル主要企業は、Ambio Pharmaceuticals、 Jiangsu Sinopep Allsin Bphrmctcl、 Chengdu Shengnuo Biotechnology、 Hybio Pharmaceutical、 Hainan Shuangcheng、 Zhejiang Paitai Biology、 Hefei KS-V Peptide Biological Technology、 JYMedtech、 GenScript、 Chinese Peptide、 Asymchem Lab、 Aurisco Pharmaceutical、 BrightGene Bio-Medical Technology、 WuXi AppTec、 Spera Nexusなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ポリペプチドAPIのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のポリペプチドAPI市場：タイプ別、2018年-2023年、2024年-2029年 世界のポリペプチドAPI市場：タイプ別市場シェア、2022年 ・インスリン、非インスリン 世界のポリペプチドAPI市場：用途別、2018年-2023年、2024年-2029年 世界のポリペプチドAPI市場：用途別市場シェア、2022年 ・医薬品、化粧品、その他 世界のポリペプチドAPI市場：地域・国別、2018年-2023年、2024年-2029年 世界のポリペプチドAPI市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるポリペプチドAPIのグローバル売上、2018年-2023年 ・主要企業におけるポリペプチドAPIのグローバル売上シェア、2022年 ・主要企業におけるポリペプチドAPIのグローバル販売量、2018年-2023年 ・主要企業におけるポリペプチドAPIのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Ambio Pharmaceuticals、 Jiangsu Sinopep Allsin Bphrmctcl、 Chengdu Shengnuo Biotechnology、 Hybio Pharmaceutical、 Hainan Shuangcheng、 Zhejiang Paitai Biology、 Hefei KS-V Peptide Biological Technology、 JYMedtech、 GenScript、 Chinese Peptide、 Asymchem Lab、 Aurisco Pharmaceutical、 BrightGene Bio-Medical Technology、 WuXi AppTec、 Spera Nexus ************************************************************* ・調査・分析レポートの概要 ポリペプチドAPI市場の定義 市場セグメント 世界のポリペプチドAPI市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のポリペプチドAPI市場規模 世界のポリペプチドAPI市場規模：2022年 VS 2029年 世界のポリペプチドAPI市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのポリペプチドAPIの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のポリペプチドAPI製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：インスリン、非インスリン ポリペプチドAPIのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：医薬品、化粧品、その他 ポリペプチドAPIの用途別グローバル売上・予測 ・地域別市場分析 地域別ポリペプチドAPI市場規模 2022年と2029年 地域別ポリペプチドAPI売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Ambio Pharmaceuticals、 Jiangsu Sinopep Allsin Bphrmctcl、 Chengdu Shengnuo Biotechnology、 Hybio Pharmaceutical、 Hainan Shuangcheng、 Zhejiang Paitai Biology、 Hefei KS-V Peptide Biological Technology、 JYMedtech、 GenScript、 Chinese Peptide、 Asymchem Lab、 Aurisco Pharmaceutical、 BrightGene Bio-Medical Technology、 WuXi AppTec、 Spera Nexus ... |
This research report provides a comprehensive analysis of the Polypeptide API market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Polypeptide API market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Polypeptide API, challenges faced by the industry, and potential opportunities for market players.
The global Polypeptide API market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Polypeptide API market presents opportunities for various stakeholders, including Pharmaceutical, Cosmetic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Polypeptide API market. Additionally, the growing consumer demand present avenues for market expansion.
The global Polypeptide API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Polypeptide API market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Polypeptide API market.
Market Overview: The report provides a comprehensive overview of the Polypeptide API market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Insulin Type, Non-Insulin Type), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Polypeptide API market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Polypeptide API market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Polypeptide API market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Polypeptide API market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Polypeptide API market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Polypeptide API market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Polypeptide API, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Polypeptide API market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Polypeptide API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Insulin Type
Non-Insulin Type
Market segment by Application
Pharmaceutical
Cosmetic
Other
Global Polypeptide API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Ambio Pharmaceuticals
Jiangsu Sinopep Allsin Bphrmctcl
Chengdu Shengnuo Biotechnology
Hybio Pharmaceutical
Hainan Shuangcheng
Zhejiang Paitai Biology
Hefei KS-V Peptide Biological Technology
JYMedtech
GenScript
Chinese Peptide
Asymchem Lab
Aurisco Pharmaceutical
BrightGene Bio-Medical Technology
WuXi AppTec
Spera Nexus
Outline of Major Chapters:
Chapter 1: Introduces the definition of Polypeptide API, market overview.
Chapter 2: Global Polypeptide API market size in revenue and volume.
Chapter 3: Detailed analysis of Polypeptide API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Polypeptide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Polypeptide API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Polypeptide API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Polypeptide API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Polypeptide API Overall Market Size
2.1 Global Polypeptide API Market Size: 2022 VS 2029
2.2 Global Polypeptide API Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Polypeptide API Sales: 2018-2029
3 Company Landscape
3.1 Top Polypeptide API Players in Global Market
3.2 Top Global Polypeptide API Companies Ranked by Revenue
3.3 Global Polypeptide API Revenue by Companies
3.4 Global Polypeptide API Sales by Companies
3.5 Global Polypeptide API Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Polypeptide API Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Polypeptide API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Polypeptide API Players in Global Market
3.8.1 List of Global Tier 1 Polypeptide API Companies
3.8.2 List of Global Tier 2 and Tier 3 Polypeptide API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Polypeptide API Market Size Markets, 2022 & 2029
4.1.2 Insulin Type
4.1.3 Non-Insulin Type
4.2 By Type – Global Polypeptide API Revenue & Forecasts
4.2.1 By Type – Global Polypeptide API Revenue, 2018-2023
4.2.2 By Type – Global Polypeptide API Revenue, 2024-2029
4.2.3 By Type – Global Polypeptide API Revenue Market Share, 2018-2029
4.3 By Type – Global Polypeptide API Sales & Forecasts
4.3.1 By Type – Global Polypeptide API Sales, 2018-2023
4.3.2 By Type – Global Polypeptide API Sales, 2024-2029
4.3.3 By Type – Global Polypeptide API Sales Market Share, 2018-2029
4.4 By Type – Global Polypeptide API Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Polypeptide API Market Size, 2022 & 2029
5.1.2 Pharmaceutical
5.1.3 Cosmetic
5.1.4 Other
5.2 By Application – Global Polypeptide API Revenue & Forecasts
5.2.1 By Application – Global Polypeptide API Revenue, 2018-2023
5.2.2 By Application – Global Polypeptide API Revenue, 2024-2029
5.2.3 By Application – Global Polypeptide API Revenue Market Share, 2018-2029
5.3 By Application – Global Polypeptide API Sales & Forecasts
5.3.1 By Application – Global Polypeptide API Sales, 2018-2023
5.3.2 By Application – Global Polypeptide API Sales, 2024-2029
5.3.3 By Application – Global Polypeptide API Sales Market Share, 2018-2029
5.4 By Application – Global Polypeptide API Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Polypeptide API Market Size, 2022 & 2029
6.2 By Region – Global Polypeptide API Revenue & Forecasts
6.2.1 By Region – Global Polypeptide API Revenue, 2018-2023
6.2.2 By Region – Global Polypeptide API Revenue, 2024-2029
6.2.3 By Region – Global Polypeptide API Revenue Market Share, 2018-2029
6.3 By Region – Global Polypeptide API Sales & Forecasts
6.3.1 By Region – Global Polypeptide API Sales, 2018-2023
6.3.2 By Region – Global Polypeptide API Sales, 2024-2029
6.3.3 By Region – Global Polypeptide API Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Polypeptide API Revenue, 2018-2029
6.4.2 By Country – North America Polypeptide API Sales, 2018-2029
6.4.3 US Polypeptide API Market Size, 2018-2029
6.4.4 Canada Polypeptide API Market Size, 2018-2029
6.4.5 Mexico Polypeptide API Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Polypeptide API Revenue, 2018-2029
6.5.2 By Country – Europe Polypeptide API Sales, 2018-2029
6.5.3 Germany Polypeptide API Market Size, 2018-2029
6.5.4 France Polypeptide API Market Size, 2018-2029
6.5.5 U.K. Polypeptide API Market Size, 2018-2029
6.5.6 Italy Polypeptide API Market Size, 2018-2029
6.5.7 Russia Polypeptide API Market Size, 2018-2029
6.5.8 Nordic Countries Polypeptide API Market Size, 2018-2029
6.5.9 Benelux Polypeptide API Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Polypeptide API Revenue, 2018-2029
6.6.2 By Region – Asia Polypeptide API Sales, 2018-2029
6.6.3 China Polypeptide API Market Size, 2018-2029
6.6.4 Japan Polypeptide API Market Size, 2018-2029
6.6.5 South Korea Polypeptide API Market Size, 2018-2029
6.6.6 Southeast Asia Polypeptide API Market Size, 2018-2029
6.6.7 India Polypeptide API Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Polypeptide API Revenue, 2018-2029
6.7.2 By Country – South America Polypeptide API Sales, 2018-2029
6.7.3 Brazil Polypeptide API Market Size, 2018-2029
6.7.4 Argentina Polypeptide API Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Polypeptide API Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Polypeptide API Sales, 2018-2029
6.8.3 Turkey Polypeptide API Market Size, 2018-2029
6.8.4 Israel Polypeptide API Market Size, 2018-2029
6.8.5 Saudi Arabia Polypeptide API Market Size, 2018-2029
6.8.6 UAE Polypeptide API Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Ambio Pharmaceuticals
7.1.1 Ambio Pharmaceuticals Company Summary
7.1.2 Ambio Pharmaceuticals Business Overview
7.1.3 Ambio Pharmaceuticals Polypeptide API Major Product Offerings
7.1.4 Ambio Pharmaceuticals Polypeptide API Sales and Revenue in Global (2018-2023)
7.1.5 Ambio Pharmaceuticals Key News & Latest Developments
7.2 Jiangsu Sinopep Allsin Bphrmctcl
7.2.1 Jiangsu Sinopep Allsin Bphrmctcl Company Summary
7.2.2 Jiangsu Sinopep Allsin Bphrmctcl Business Overview
7.2.3 Jiangsu Sinopep Allsin Bphrmctcl Polypeptide API Major Product Offerings
7.2.4 Jiangsu Sinopep Allsin Bphrmctcl Polypeptide API Sales and Revenue in Global (2018-2023)
7.2.5 Jiangsu Sinopep Allsin Bphrmctcl Key News & Latest Developments
7.3 Chengdu Shengnuo Biotechnology
7.3.1 Chengdu Shengnuo Biotechnology Company Summary
7.3.2 Chengdu Shengnuo Biotechnology Business Overview
7.3.3 Chengdu Shengnuo Biotechnology Polypeptide API Major Product Offerings
7.3.4 Chengdu Shengnuo Biotechnology Polypeptide API Sales and Revenue in Global (2018-2023)
7.3.5 Chengdu Shengnuo Biotechnology Key News & Latest Developments
7.4 Hybio Pharmaceutical
7.4.1 Hybio Pharmaceutical Company Summary
7.4.2 Hybio Pharmaceutical Business Overview
7.4.3 Hybio Pharmaceutical Polypeptide API Major Product Offerings
7.4.4 Hybio Pharmaceutical Polypeptide API Sales and Revenue in Global (2018-2023)
7.4.5 Hybio Pharmaceutical Key News & Latest Developments
7.5 Hainan Shuangcheng
7.5.1 Hainan Shuangcheng Company Summary
7.5.2 Hainan Shuangcheng Business Overview
7.5.3 Hainan Shuangcheng Polypeptide API Major Product Offerings
7.5.4 Hainan Shuangcheng Polypeptide API Sales and Revenue in Global (2018-2023)
7.5.5 Hainan Shuangcheng Key News & Latest Developments
7.6 Zhejiang Paitai Biology
7.6.1 Zhejiang Paitai Biology Company Summary
7.6.2 Zhejiang Paitai Biology Business Overview
7.6.3 Zhejiang Paitai Biology Polypeptide API Major Product Offerings
7.6.4 Zhejiang Paitai Biology Polypeptide API Sales and Revenue in Global (2018-2023)
7.6.5 Zhejiang Paitai Biology Key News & Latest Developments
7.7 Hefei KS-V Peptide Biological Technology
7.7.1 Hefei KS-V Peptide Biological Technology Company Summary
7.7.2 Hefei KS-V Peptide Biological Technology Business Overview
7.7.3 Hefei KS-V Peptide Biological Technology Polypeptide API Major Product Offerings
7.7.4 Hefei KS-V Peptide Biological Technology Polypeptide API Sales and Revenue in Global (2018-2023)
7.7.5 Hefei KS-V Peptide Biological Technology Key News & Latest Developments
7.8 JYMedtech
7.8.1 JYMedtech Company Summary
7.8.2 JYMedtech Business Overview
7.8.3 JYMedtech Polypeptide API Major Product Offerings
7.8.4 JYMedtech Polypeptide API Sales and Revenue in Global (2018-2023)
7.8.5 JYMedtech Key News & Latest Developments
7.9 GenScript
7.9.1 GenScript Company Summary
7.9.2 GenScript Business Overview
7.9.3 GenScript Polypeptide API Major Product Offerings
7.9.4 GenScript Polypeptide API Sales and Revenue in Global (2018-2023)
7.9.5 GenScript Key News & Latest Developments
7.10 Chinese Peptide
7.10.1 Chinese Peptide Company Summary
7.10.2 Chinese Peptide Business Overview
7.10.3 Chinese Peptide Polypeptide API Major Product Offerings
7.10.4 Chinese Peptide Polypeptide API Sales and Revenue in Global (2018-2023)
7.10.5 Chinese Peptide Key News & Latest Developments
7.11 Asymchem Lab
7.11.1 Asymchem Lab Company Summary
7.11.2 Asymchem Lab Business Overview
7.11.3 Asymchem Lab Polypeptide API Major Product Offerings
7.11.4 Asymchem Lab Polypeptide API Sales and Revenue in Global (2018-2023)
7.11.5 Asymchem Lab Key News & Latest Developments
7.12 Aurisco Pharmaceutical
7.12.1 Aurisco Pharmaceutical Company Summary
7.12.2 Aurisco Pharmaceutical Business Overview
7.12.3 Aurisco Pharmaceutical Polypeptide API Major Product Offerings
7.12.4 Aurisco Pharmaceutical Polypeptide API Sales and Revenue in Global (2018-2023)
7.12.5 Aurisco Pharmaceutical Key News & Latest Developments
7.13 BrightGene Bio-Medical Technology
7.13.1 BrightGene Bio-Medical Technology Company Summary
7.13.2 BrightGene Bio-Medical Technology Business Overview
7.13.3 BrightGene Bio-Medical Technology Polypeptide API Major Product Offerings
7.13.4 BrightGene Bio-Medical Technology Polypeptide API Sales and Revenue in Global (2018-2023)
7.13.5 BrightGene Bio-Medical Technology Key News & Latest Developments
7.14 WuXi AppTec
7.14.1 WuXi AppTec Company Summary
7.14.2 WuXi AppTec Business Overview
7.14.3 WuXi AppTec Polypeptide API Major Product Offerings
7.14.4 WuXi AppTec Polypeptide API Sales and Revenue in Global (2018-2023)
7.14.5 WuXi AppTec Key News & Latest Developments
7.15 Spera Nexus
7.15.1 Spera Nexus Company Summary
7.15.2 Spera Nexus Business Overview
7.15.3 Spera Nexus Polypeptide API Major Product Offerings
7.15.4 Spera Nexus Polypeptide API Sales and Revenue in Global (2018-2023)
7.15.5 Spera Nexus Key News & Latest Developments
8 Global Polypeptide API Production Capacity, Analysis
8.1 Global Polypeptide API Production Capacity, 2018-2029
8.2 Polypeptide API Production Capacity of Key Manufacturers in Global Market
8.3 Global Polypeptide API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Polypeptide API Supply Chain Analysis
10.1 Polypeptide API Industry Value Chain
10.2 Polypeptide API Upstream Market
10.3 Polypeptide API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Polypeptide API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer